Literature DB >> 30361625

Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.

Diego Llovet1,1, Mardie Serenity1, Lesley Gotlib Conn1,1, Caroline A Bravo1, Bronwen R McCurdy1, Catherine Dubé1,1, Nancy N Baxter1,1, Lawrence Paszat1,1, Linda Rabeneck1,1, Amanda Peters1, Jill Tinmouth1,1.   

Abstract

OBJECTIVES: Follow-up colonoscopy rates among persons with positive fecal occult blood test results (FOBT + ) remain suboptimal in many jurisdictions. In Ontario, Canada, primary care providers (PCPs) are responsible for arranging follow-up colonoscopies. The objectives were to understand the reasons for a lack of follow-up colonoscopy and any action plans to address follow-up.
METHODS: Semi-structured interviews were conducted with 30 FOBT+ persons and 30 PCPs in Ontario. Eligible FOBT+ persons were identified through administrative databases and included those aged 50-74, with a 6-12 month old FOBT+, no follow-up colonoscopy, and no prior colorectal cancer diagnosis or colectomy. Eligible PCPs had ≥1 rostered FOBT+ person without follow-up colonoscopy. Transcripts were analyzed inductively using Nvivo 11 (QSR International Pty Ltd., 2015).
RESULTS: Reasons for lack of follow-up colonoscopy were: person and/or provider believed the FOBT + was a false positive; person was afraid of colonoscopy; person had other health issues; and breakdown in communication of FOBT+ results or colonoscopy appointments. PCPs who initially recommended follow-up colonoscopy did not change the minds of the persons who dismissed the FOBT+ as a false positive and/or who were afraid of the procedure. These FOBT+ persons negotiated an alternative follow-up action plan including repeating the FOBT or not following-up.
CONCLUSIONS: PCPs may not adequately counsel FOBT+ persons who believe the FOBT+ is a false positive and/or fear colonoscopy. PCPs may lack fail-safe systems to communicate FOBT+ results and colonoscopy appointments. Using navigators may help address these barriers and increase follow-up rates.

Entities:  

Mesh:

Year:  2018        PMID: 30361625      PMCID: PMC6768592          DOI: 10.1038/s41395-018-0381-4

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  40 in total

1.  Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice.

Authors:  Ann Oluloro; Amanda F Petrik; Ann Turner; Tanya Kapka; Jennifer Rivelli; Patricia A Carney; Somnath Saha; Gloria D Coronado
Journal:  J Community Health       Date:  2016-08

2.  Three approaches to qualitative content analysis.

Authors:  Hsiu-Fang Hsieh; Sarah E Shannon
Journal:  Qual Health Res       Date:  2005-11

Review 3.  Organized colorectal cancer screening in integrated health care systems.

Authors:  Theodore R Levin; Laura Jamieson; Daniel A Burley; Juan Reyes; Michael Oehrli; Cindy Caldwell
Journal:  Epidemiol Rev       Date:  2011-06-27       Impact factor: 6.222

4.  Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices.

Authors:  Adriano Correia; Linda Rabeneck; Nancy N Baxter; Lawrence F Paszat; Rinku Sutradhar; Lingsong Yun; Jill Tinmouth
Journal:  Prev Med       Date:  2015-04-18       Impact factor: 4.018

5.  Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research.

Authors:  C Pope; N Mays
Journal:  BMJ       Date:  1995-07-01

6.  Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.

Authors:  Nadeem Baig; Ronald E Myers; Barbara J Turner; James Grana; Todd Rothermel; Neil Schlackman; David S Weinberg
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

7.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

8.  Time allocation in primary care office visits.

Authors:  Ming Tai-Seale; Thomas G McGuire; Weimin Zhang
Journal:  Health Serv Res       Date:  2007-10       Impact factor: 3.402

9.  Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system.

Authors:  Sharon S Laing; Andy Bogart; Jessica Chubak; Sharon Fuller; Beverly B Green
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-11-12       Impact factor: 4.254

10.  Soliciting the patient's agenda: have we improved?

Authors:  M K Marvel; R M Epstein; K Flowers; H B Beckman
Journal:  JAMA       Date:  1999-01-20       Impact factor: 56.272

View more
  9 in total

1.  Making FIT Count: Maximizing Appropriate Use of the Fecal Immunochemical Test for Colorectal Cancer Screening Programs.

Authors:  Vivy T Cusumano; Folasade P May
Journal:  J Gen Intern Med       Date:  2020-03-03       Impact factor: 5.128

2.  Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.

Authors:  Vivy T Cusumano; Anthony Myint; Edgar Corona; Liu Yang; Jennifer Bocek; Antonio G Lopez; Marcela Zhou Huang; Naveen Raja; Anna Dermenchyan; Lily Roh; Maria Han; Daniel Croymans; Folasade P May
Journal:  Dig Dis Sci       Date:  2021-02-20       Impact factor: 3.199

3.  Preference and Experience of Colonic Examination for Participants Presenting to Hospitals with a Positive Fecal Immunochemical Test Result.

Authors:  Takashi Kato; Koichi Nagata; Junta Yamamichi; Soichi Tanaka; Tetsuro Honda; Norihito Shimizu; Kenichi Utano; Michiaki Hirayama; Hiroshi Matsumoto; Shoichi Horita
Journal:  Patient Prefer Adherence       Date:  2020-10-22       Impact factor: 2.711

4.  Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit.

Authors:  Samir Gupta; Gloria D Coronado; Keith Argenbright; Alison T Brenner; Sheila F Castañeda; Jason A Dominitz; Beverly Green; Rachel B Issaka; Theodore R Levin; Daniel S Reuland; Lisa C Richardson; Douglas J Robertson; Amit G Singal; Michael Pignone
Journal:  CA Cancer J Clin       Date:  2020-06-25       Impact factor: 286.130

5.  Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy.

Authors:  Vivy T Cusumano; Edgar Corona; Diana Partida; Liu Yang; Christine Yu; Folasade P May
Journal:  BMC Gastroenterol       Date:  2020-04-19       Impact factor: 3.067

6.  Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.

Authors:  Lucinda Bertels; Peter Lucassen; Kristel van Asselt; Evelien Dekker; Henk van Weert; Bart Knottnerus
Journal:  Scand J Prim Health Care       Date:  2020-11-13       Impact factor: 2.581

7.  Timely Colonoscopy After Positive Fecal Immunochemical Tests in the Veterans Health Administration: A Qualitative Assessment of Current Practice and Perceived Barriers.

Authors:  Ashley C Mog; Peter S Liang; Lucas M Donovan; George G Sayre; Aasma Shaukat; Folasade P May; Thomas J Glorioso; Michelle A Jorgenson; Gordon Blake Wood; Candice Mueller; Jason A Dominitz
Journal:  Clin Transl Gastroenterol       Date:  2022-02-01       Impact factor: 4.396

8.  Could a Behavioral Model Explain Adherence to Second-Level Colonoscopy for Colon Cancer Screening? Results of a Cross-Sectional Study of the Palermo Province Population.

Authors:  Giuseppa Minutolo; Palmira Immordino; Alessia Dolce; Mario Valenza; Emanuele Amodio; Walter Mazzucco; Alessandra Casuccio; Vincenzo Restivo
Journal:  Int J Environ Res Public Health       Date:  2022-02-27       Impact factor: 3.390

9.  Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System.

Authors:  Rachel B Issaka; Ari Bell-Brown; Cyndy Snyder; Dana L Atkins; Lisa Chew; Bryan J Weiner; Lisa Strate; John M Inadomi; Scott D Ramsey
Journal:  JAMA Netw Open       Date:  2021-08-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.